News from saluda medical A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

May 18, 2022, 09:00 ET Saluda Medical Announces Robust Scientific Presence at 2022 International Neuromodulation Society (INS) World Congress

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...

Apr 20, 2022, 09:00 ET Saluda Medical Appoints Robert Palmisano to Board of Directors

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...

Mar 08, 2022, 09:00 ET Saluda Medical Receives FDA Approval for the Evoke® Spinal Cord Stimulation System to Treat Chronic Intractable Pain

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...

Mar 02, 2022, 09:00 ET Saluda Medical Announces $125M Equity Financing Led by Redmile Group LLC and New Investors Fidelity Management & Research Company LLC and T. Rowe Price Associates, Inc.

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...

Feb 23, 2022, 09:00 ET Saluda Medical Appoints Doug Godshall as Chairman of the Board

Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company on a mission to revolutionize the field of neuromodulation with an...

Jan 10, 2022, 09:00 ET Publication of Two-Year EVOKE Double-Blind Randomized Controlled Trial Results in JAMA Neurology Demonstrate Sustained Superiority of Evoke® Closed-Loop over Open-Loop Spinal Cord Stimulation

Saluda Medical Pty Limited ("Saluda Medical"), a global company on a mission to revolutionize the field of neuromodulation with an emerging portfolio ...

Nov 16, 2021, 09:00 ET Saluda Medical Expands Executive Leadership Team with Vision for Growth

Saluda Medical Pty Limited ("Saluda Medical"), the pioneer in neuromodulation platform of closed-loop technologies designed to achieve unparalleled...

May 10, 2021, 08:30 ET Saluda Medical Announces Publication of 24-Month Spinal Cord Stimulation Results with the Evoke® System

Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of closed-loop spinal cord stimulation (SCS) for the treatment of ...

Feb 12, 2021, 09:05 ET Saluda Medical Announces Executive Leadership Changes

Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of novel closed-loop spinal cord stimulation (SCS) for the...

Jan 20, 2021, 15:16 ET Saluda Medical Announces Highlights from 2021 North American Neuromodulation Society (NANS) Meeting

Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of closed-loop spinal cord stimulation for the treatment of...

Jan 07, 2021, 09:00 ET Saluda Medical Announces Scientific Presentations at 2021 North American Neuromodulation Society (NANS) Meeting

Saluda Medical Pty Limited ("Saluda Medical"), developer of the Evoke® Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic...

Dec 22, 2020, 08:00 ET NICE Publishes Briefing on Saluda's Evoke Closed-Loop Spinal Cord Stimulation (SCS) System

Saluda Medical Pty Limited ("Saluda Medical") announced today that the UK's National Institute for Health and Care Excellence (NICE) issued a Medtech ...

Jun 09, 2020, 08:00 ET Saluda Medical Appoints Jim Schuermann as President and Robert Gaffney as Chief Operating Officer

Saluda Medical Pty Limited ("Saluda Medical"), a global neuromodulation company leading the development and commercialization of data-driven,...

Jan 28, 2020, 17:45 ET Saluda Medical Publiceert Definitieve Langetermijnresultaten na 24 Maanden Avalon-studie en Resultaten na 12 Maanden Evoke Hoofdstudie in de V.S.

Jan 22, 2020, 05:21 ET Saluda Medical Belicht Meerdere Presentaties Over het Evoke® ECAP-Controlled, Closed-Loop SCS-Systeem op NANS Jaarcongres

Jan 21, 2020, 07:00 ET Saluda Medical Highlights Multiple Presentations Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System at NANS Annual Meeting

Saluda Medical Pty Limited ("Saluda Medical") today announced that data from multiple studies evaluating the company's Evoke® ECAP-Controlled,...

Dec 23, 2019, 00:14 ET Saluda Medical's Resultaten in Amerikaanse Evoke Hoofdstudie Gepubliceerd in The Lancet Neurology

Dec 20, 2019, 18:43 ET Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology

Saluda Medical Pty Limited ("Saluda Medical") today announced The Lancet Neurology journal published results from the U.S. Pivotal Study...

Sep 16, 2019, 00:01 ET Saluda Medical kondigt Europese commerciële lancering van Evoke® aan, het eerste en enige ECAP-Controlled, Closed-Loop SCS-systeem voor de verlichting van chronische pijn

Sep 16, 2019, 00:01 ET Saluda Medical Announces European Commercial Launch of Evoke®, the First and Only ECAP-Controlled, Closed-Loop SCS System for Chronic Pain Relief

Saluda Medical Pty Limited ("Saluda Medical") today announced the award of CE Mark and the European commercial launch of the Evoke® ECAP-Controlled,...

Jun 28, 2019, 04:00 ET Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group

Saluda Medical Pty Limited ("Saluda Medical") today announced that it has secured $75 million in equity financing from Boston Scientific Corporation...

Jun 27, 2019, 04:00 ET Saluda Medical Secures Debt Financing From Medtronic

Saluda Medical Pty Limited ("Saluda Medical") today announced that it has secured a four-year term loan agreement with Medtronic, to fund continued...

Jun 03, 2019, 04:00 ET Saluda Medical Announces Clinical Study Results for Evoke® ECAP-Controlled, Closed-Loop SCS System for the Treatment of Chronic Pain

Saluda Medical Pty Limited ("Saluda Medical") today announced data from two clinical studies evaluating the performance of the company's Evoke®...

May 20, 2019, 04:00 ET Saluda Medical Announces New 3-Month, 12-Month and 18-Month Data Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System to be Presented at 14th INS World Congress

Saluda Medical Pty Limited ("Saluda Medical") today announced that new data from multiple studies evaluating the company's Evoke® ECAP-Controlled,...

May 30, 2017, 04:00 ET Saluda Medical Secures AU$53 Million in Series D Financing

Saluda Medical Pty Limited, a medical device company developing a platform of closed-loop neuromodulation technologies based on neural response to...